Lv36
322 积分 2025-11-04 加入
Efficacy and Safety of Apixaban Compared with Warfarin for Stroke Prevention in Patients with Atrial Fibrillation from East Asia: A Subanalysis of the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial
1天前
求助中
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
1天前
求助中
Clinical outcomes, edoxaban concentration, and anti-factor Xa activity of Asian patients with atrial fibrillation compared with non-Asians in the ENGAGE AF-TIMI 48 trial
1天前
已完结
Safety and effectiveness of dabigatran at 2 years: Final outcomes from Phase II of the GLORIA-AF registry program
1天前
已完结
中国心房颤动管理指南（2025）
2天前
已完结
Prevalence, Incidence, and Lifetime Risk of Atrial Fibrillation in China: New Insights Into the Global Burden of Atrial Fibrillation
2天前
已完结
Effect of 22 CYP2D6 variants found in the Chinese population on tolterodine metabolism in vitro
7天前
已关闭
Chorea associated with Huntington's disease: To treat or not to treat?
15天前
已完结
Subdural Hematoma as a Serious Complication of Huntington’s Disease: An Observational Study
17天前
已完结
Chinese guidelines for diagnosis and treatment of Huntington′s disease 2023
21天前
已完结
皖公网安备34019202002308
